Liquidia Corporation
IPOJust breathe
Public · Morrisville, United States · Founded 2004
- Headquarters
- Morrisville, North Carolina
- Employees
- 51–200
- Founded
- 2004
- Business Model
- B2B
- Website
- liquidia.com
- Last Round
- Venture RoundJun 2025
- Rounds
- 6
- Type
- Public
About
Liquidia Corporation is a publicly traded biopharmaceutical company focused on developing and commercializing innovative therapies for rare cardiopulmonary diseases, particularly pulmonary arterial hypertension (PAH). The company leverages its proprietary PRINT nanotechnology platform to engineer inhaled therapies with enhanced efficacy and tolerability. Liquidia trades on Nasdaq as LQDA and is headquartered in Morrisville, North Carolina.
Summary
Liquidia Corporation is a Biotech company based in Morrisville, United States, founded in 2004. Its most recent funding was a Venture Round round in Jun 2025. Investors include New Enterprise Associates, Healthcare Royalty Partners and Patient Square Capital.
Tech & App Stack
5 technologies & apps tracked
Create a free account — 25 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 25 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jun 2025
Sign up to see all 6 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...